Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women

Robin C Vanderpool, Emily Van Meter Dressler, Lindsay R Stradtman, Richard A Crosby, Robin C Vanderpool, Emily Van Meter Dressler, Lindsay R Stradtman, Richard A Crosby

Abstract

Purpose: Uptake and completion of the 3-dose human papillomavirus (HPV) vaccine is important for the primary prevention of cervical cancer. However, HPV vaccination rates among adolescent females and young women remain low in certain geographic areas of the United States, including Appalachia. Although greater fatalistic beliefs have been previously associated with lower rates of preventive cancer behaviors among adults, little research exists on the impact of fatalism on HPV vaccination behaviors, especially among younger individuals. Therefore, the purpose of this study was to examine the association between fatalistic beliefs and completion of the full HPV vaccine series among young women, ages 18-26, in Appalachian Kentucky.

Results: Data from this study were from a baseline survey completed by 344 women randomized into a communication intervention trial focused on increasing adherence to the 3-dose HPV vaccine series. Principal components analysis was used to construct 2 fatalism-related subscales from 8 survey questions.

Findings: In a controlled analysis, 1 subscale--"lack of control over cancer"--was significantly associated with not completing the full HPV vaccine series. In a rural area that experiences higher rates of cervical cancer, poverty, limited access to health care, and negative cancer-related attitudes and experiences, fatalism may be common, even among young people.

Conclusion: Future educational and interventional research addressing fatalistic beliefs in a culturally sensitive manner may be warranted to improve HPV vaccination behaviors and impact cancer disparities among Appalachian women.

Keywords: Appalachia; HPV vaccination; health disparities; health promotion; utilization of health services.

Conflict of interest statement

Disclosures: The authors have no conflicts of interest to disclose.

© 2015 National Rural Health Association.

References

    1. Genital HPV infection – fact sheet. Centers for Disease Control and Prevention website. Available at: . Updated March 20, 2014. Accessed June 11, 2014.
    1. Centers for Disease Control and Prevention (CDC) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep. 2010;59(20):626–629.
    1. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2014;63(Rr-05):1–30.
    1. Williams WW, Lu PJ, O’Halloran A, et al. Noninfluenza vaccination coverage among adults – United States, 2012. MMWR Morb and Mort Wkly Rep. 2014;63(5):95–102.
    1. Crosby RA, Casey BR, Vanderpool R, Collins T, Moore GR. Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates. J Rural Health. 2011;27(4):380–384.
    1. Reiter PL, Katz ML, Paskett ED. HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities. Cancer Epidemiol Biomarkers Prev. 2012;21(12):2220–2230.
    1. Reiter PL, Katz ML, Ruffin MT, et al. HPV prevalence among women from Appalachia: results from the CARE project [published correction appears in PLoS One. 2013;8(10)10.1371/annotation/7a4cfd0a-cf77–430e-89a0-b2576268e2eb] PLoS One. 2013;8(8):e74276.
    1. Centers for Disease Control and Prevention (CDC) Cancer death rates–Appalachia, 1994–1998. MMWR Morb Mortal Wkly Rep. 2002;51(24):527–529.
    1. Wingo PA, Tucker TC, Jamison PM, et al. Cancer in Appalachia, 2001–2003. Cancer. 2008;112(1):181–192.
    1. Yabroff KR, Lawrence WF, King JC, et al. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment? J Rural Health. 2005;21(2):149–157.
    1. Reiter PL, Fisher JL, Hudson AG, Tucker TC, Plascak JJ, Paskett ED. Assessing the burden of HPV-related cancers in Appalachia. Hum Vaccin Immunother. 2013;9(1):90–96.
    1. Lyttle NL, Stadelman K. Assessing awareness and knowledge of breast and cervical cancer among Appalachian women. Prev Chronic Dis. 2006;3(4):A125.
    1. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine. 2009;27(30):3945–3952.
    1. Head KJ, Cohen EL. Young women’s perspectives on cervical cancer prevention in Appalachian Kentucky. Qual Health Res. 2012;22(4):476–487.
    1. Head KJ, Vanderpool RC, Mills LA. Health care providers’ perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky. Public Health Nurs. 2013;30(4):351–360.
    1. Mills LA, Head KJ, Vanderpool RC. HPV vaccination among young adult women: a perspective from Appalachian Kentucky. Prev Chronic Dis. 2013;10:E17.
    1. Casey BR, Crosby RA, Vanderpool RC, Dignan M, Bates W. Predictors of initial uptake of human papillomavirus vaccine uptake among rural Appalachian young women. J Prim Prev. 2013;34(1–2):71–80.
    1. Powe BD, Finnie R. Cancer fatalism: the state of the science. Cancer Nurs. 2003;26(6):454–467.
    1. Niederdeppe J, Levy AG. Fatalistic beliefs about cancer prevention and three prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2007;16(5):998–1003.
    1. Miles A, Voorwinden S, Chapman S, Wardle J. Psychologic predictors of cancer information avoidance among older adults: the role of cancer fear and fatalism. Cancer Epidemiol Biomarkers Prev. 2008;17(8):1872–1879.
    1. Miles A, Rainbow S, von Wagner C. Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2132–2140.
    1. Flynn PM, Betancourt H, Ormseth SR. Culture, emotion, and cancer screening: an integrative framework for investigating health behavior. Ann Behav Med. 2011;42(1):79–90.
    1. Shen LJ, Condit CM, Wright L. The psychometric property and validation of a fatalism scale. Psychol Health. 2009;24(5):597–613.
    1. Hall AG, Khoury AJ, Lopez EDS, Lisovicz N, Avis-Williams A, Mitra A. Breast cancer fatalism: the role of women’s perceptions of the health care system. J Health Care Poor Underserved. 2008;19(4):1321–1335.
    1. Powe BD, Johnson A. Fatalism as a barrier to cancer screening among African-Americans: Philosophical perspectives. J Relig Health. 1995;34(2):119–125.
    1. Ramirez AS, Rutten LJF, Oh A, et al. Perceptions of cancer controllability and cancer risk knowledge: the moderating role of race, ethnicity, and acculturation. J Cancer Educ. 2013;28(2):254–261.
    1. Fernandez ME, McCurdy SA, Arvey SR, et al. HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health. 2009;14(6):607–624.
    1. Beeken RJ, Simon AE, von Wagner C, Whitaker KL, Wardle J. Cancer fatalism: deterring early presentation and increasing social inequalities? Cancer Epidemiol Biomarkers Prev. 2011;20(10):2127–2131.
    1. Mayo RM, Ureda JR, Parker VG. Importance of fatalism in understanding mammography screening in rural elderly women. J Women Aging. 2001;13(1):57–72.
    1. Befort CA, Nazir N, Engelman K, Choi W. Fatalistic cancer beliefs and information sources among rural and urban adults in the USA. J Cancer Educ. 2013;28(3):521–526.
    1. Shell R, Tudiver F. Barriers to cancer screening by rural Appalachian primary care providers. J Rural Health. 2004;20(4):368–373.
    1. Royse D, Dignan M. Fatalism and cancer screening in Appalachian Kentucky. Fam Community Health. 2011;34(2):126–133.
    1. Friedell GH, Linville LH, Hullet S. Cancer control in rural Appalachia. Cancer. 1998;83(8):1868–1871.
    1. Nan X, Zhao X, Briones R. Parental cancer beliefs and trust in health information from medical authorities as predictors of HPV vaccine acceptability. J Health Commun. 2014;19(1):100–114.
    1. Vanderpool RC, Cohen EL, Crosby RA, et al. “1–2–3 Pap” intervention improves HPV vaccine series completion among Appalachian women. J Commun. 2013;63(1):95–115.
    1. Rural-Urban Continuum Codes. United States Department of Agriculture website. Available at: . Updated May 10, 2013. Accessed October 13, 2014.
    1. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. 1st. Englewood Cliffs, NJ: Prentice-Hall; 1980.
    1. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–114.
    1. Crosby R, Schoenberg N, Hopenhayn C, Moore G, Melhan W. Correlates of intent to be vaccinated against human papillomavirus: an exploratory study of college-aged women. Sex Health. 2007;4(1):71–73.
    1. Wallston KA, Wallston BS, DeVellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr. 1978;6(2):160–170.
    1. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th. Boston, MA: Allyn and Bacon; 2001.
    1. O’Rourke N, Hatcher L, Stepanski EJ, Hatcher L. A Step-by-Step Approach to Using SAS for Univariate & Multivariate Statistics. 2nd. Cary, NC: SAS Institute Inc;
    1. Hatcher J, Dignan MB, Schoenberg N. How do rural health care providers and patients view barriers to colorectal cancer screening? Insights from Appalachian Kentucky. Nurs Clin North Am. 2011;46(2):181–192. vi.
    1. Drew EM, Schoenberg NE. Deconstructing fatalism: ethnographic perspectives on women’s decision making about cancer prevention and treatment. Med Anthropol Q. 2011;25(2):164–182.
    1. Hutson SP, Dorgan KA, Phillips AN, Behringer B. The mountains hold things in: the use of community research review work groups to address cancer disparities in Appalachia. Oncol Nurs Forum. 2007;34(6):1133–1139.
    1. Vanderpool RC, Huang B. Cancer risk perceptions, beliefs, and physician avoidance in Appalachia: results from the 2008 HINTS survey. J Health Commun. 2010;15(Suppl 3):78–91.
    1. Witte K. Putting the fear back into fear appeals: the extended parallel process model. Commun Monogr. 1992;59(4):329.
    1. Freeman HP. Cancer in the socioeconomically disadvantaged. CA Cancer J Clin. 1989;39(5):266–288.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner